Yixintang Pharmaceutical Group Co Ltd
SZSE:002727
Intrinsic Value
Yixintang Pharmaceutical Group Co., Ltd. engages in the pharmaceutical retail chain and pharmaceutical wholesale business. [ Read More ]
The intrinsic value of one
Yixintang Pharmaceutical Group Co Ltd
stock under the Base Case scenario is
37.6
CNY.
Compared to the current market price of 19.74 CNY,
Yixintang Pharmaceutical Group Co Ltd
is
Undervalued by 48%.
Yixintang Pharmaceutical Group Co Ltd's market capitalization is 11.7B CNY.
Yixintang Pharmaceutical Group Co Ltd stock price is 19.74 CNY.
Yixintang Pharmaceutical Group Co Ltd stock price (19.74 CNY) is 48% less than its Intrinsic Value (37.6 CNY).
Yixintang Pharmaceutical Group Co Ltd stock price (19.74 CNY) is 46% less than its DCF Value (36.29 CNY). Open DCF Valuation
Yixintang Pharmaceutical Group Co Ltd stock price (19.74 CNY) is 49% less than its Relative Value (38.92 CNY). Open Relative Valuation
Yixintang Pharmaceutical Group Co Ltd has upside potential of 43% compared to the average analyst price target.
Open Wall St Estimates
Yixintang Pharmaceutical Group Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 12% to 11%.
Yixintang Pharmaceutical Group Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 11%.
Yixintang Pharmaceutical Group Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 16% to 14%.
Yixintang Pharmaceutical Group Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 14%.
Yixintang Pharmaceutical Group Co Ltd has positive three-year average ROIC (Return on Invested Capital): 12%. The company is efficient at using invested capital to generate operating income.
Yixintang Pharmaceutical Group Co Ltd's Revenue has grown by 13% over the past 12 months.
Yixintang Pharmaceutical Group Co Ltd has positive Operating Income for the last twelve months.
Yixintang Pharmaceutical Group Co Ltd has positive Net Income for the last twelve months.
Yixintang Pharmaceutical Group Co Ltd's Revenue is forecast to grow at a rate of 11% per year over the next 3 years.
Yixintang Pharmaceutical Group Co Ltd has positive Net Debt. This means that the company has more debt (4B CNY) than cash and short-term investments (3B CNY).
Yixintang Pharmaceutical Group Co Ltd has positive three-year average ROE (Return on Equity): 15%. The company is efficient at transforming stockholders' equity into net income.
Yixintang Pharmaceutical Group Co Ltd's short-term assets (10B CNY) exceed its short-term liabilties (7B CNY).
Yixintang Pharmaceutical Group Co Ltd's Revenue has been growing by 15% per year for the last 3 years.
Yixintang Pharmaceutical Group Co Ltd has positive Free Cash Flow for the last twelve months.
Yixintang Pharmaceutical Group Co Ltd's Altman Z-Score is equal to 2.93.
Yixintang Pharmaceutical Group Co Ltd has positive Gross Profit for the last twelve months.
Yixintang Pharmaceutical Group Co Ltd's long-term assets (16B CNY) exceed its long-term liabilties (8B CNY).
Yixintang Pharmaceutical Group Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.47.
Valuation Backtest
Yixintang Pharmaceutical Group Co Ltd
Run backtest to discover the historical profit from buying and selling
Yixintang Pharmaceutical Group Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Yixintang Pharmaceutical Group Co Ltd
Balance Sheet Decomposition
Yixintang Pharmaceutical Group Co Ltd
| Current Assets | 9.6B |
| Cash & Short-Term Investments | 3.3B |
| Receivables | 2.1B |
| Other Current Assets | 4.1B |
| Non-Current Assets | 6.8B |
| Long-Term Investments | 151.4m |
| PP&E | 3.9B |
| Intangibles | 1.7B |
| Other Non-Current Assets | 1B |
| Current Liabilities | 6.5B |
| Accounts Payable | 2.8B |
| Accrued Liabilities | 270.4m |
| Short-Term Debt | 1.9B |
| Other Current Liabilities | 1.5B |
| Non-Current Liabilities | 1.9B |
| Long-Term Debt | 1.8B |
| Other Non-Current Liabilities | 139.3m |
Earnings Waterfall
Yixintang Pharmaceutical Group Co Ltd
|
Revenue
|
18.2B
CNY
|
|
Cost of Revenue
|
-12.1B
CNY
|
|
Gross Profit
|
6.1B
CNY
|
|
Operating Expenses
|
-4.7B
CNY
|
|
Operating Income
|
1.4B
CNY
|
|
Other Expenses
|
-356.1m
CNY
|
|
Net Income
|
1B
CNY
|
Free Cash Flow Analysis
Yixintang Pharmaceutical Group Co Ltd
Profitability Score
Profitability Due Diligence
Yixintang Pharmaceutical Group Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Yixintang Pharmaceutical Group Co Ltd's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Yixintang Pharmaceutical Group Co Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Score
Yixintang Pharmaceutical Group Co Ltd's solvency score is 59/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Yixintang Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for
Yixintang Pharmaceutical Group Co Ltd
is 28.17 CNY
with a low forecast of 19.49 CNY and a high forecast of 45.51 CNY.
Shareholder Return
Price
Yixintang Pharmaceutical Group Co Ltd
| Average Annual Return | 8.35% |
| Standard Deviation of Annual Returns | 28.72% |
| Max Drawdown | -63% |
| Market Capitalization | 11.7B CNY |
| Shares Outstanding | 596 023 425 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Yixintang Pharmaceutical Group Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Yixintang Pharmaceutical Group Co., Ltd. engages in the pharmaceutical retail chain and pharmaceutical wholesale business. The company is headquartered in Kunming, Yunnan and currently employs 32,503 full-time employees. The company went IPO on 2014-07-02. The Company’s main products include traditional Chinese medicines, western medicines, medical equipment, birth control products and disinfection products, among others. The firm distributes its products through regular chain drugstores. The firm mainly operates its business in domestic market, with southwest area of China as its main market.
Contact
IPO
Employees
Officers
The intrinsic value of one
Yixintang Pharmaceutical Group Co Ltd
stock under the Base Case scenario is
37.6
CNY.
Compared to the current market price of 19.74 CNY,
Yixintang Pharmaceutical Group Co Ltd
is
Undervalued by 48%.
You don't have any saved screeners yet
